Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Herpes Simplex
Interventions: Neem Based External Application Cream; Other
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 18 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Whittier, California

Conditions: Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
Interventions: Sham comparator, DrugSorb-ATR system; Device
Lead sponsor: CytoSorbents, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 27
States / cities: Sacramento, California • Denver, Colorado • New Haven, Connecticut + 22 more

Conditions: Breast Cancer, Lymph Node Mapping, Sentinel Lymph Node Biopsy
Interventions: IC2000 and SPY-PHI, Tc-99m radioactive colloid and Gamma Probe; Combination Product
Lead sponsor: Novadaq Technologies ULC, now a part of Stryker; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 5
States / cities: Scottsdale, Arizona • Washington D.C., District of Columbia • Jacksonville, Florida + 2 more

Conditions: Diabetes Mellitus
Interventions: Well-controlled diabetic (WC), Poorly controlled diabetics (PC); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 85 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Houston, Texas • Seattle, Washington

Conditions: Soft Tissue Neoplasm, Soft Tissue Cancer, Soft Tissue Lesion
Interventions: Medical Record Review; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Needle Phobia
Interventions: Lidocaine patch 4%, Placebo Patch, 1% Lidocaine Skin Wheal; Drug · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Lung Cancer
Interventions: Screening; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 82 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Hair Removal
Interventions: Hair2Go (Mē); Device
Lead sponsor: Syneron Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Placebo (for MN-166), MN-166, riluzole; Drug
Lead sponsor: MediciNova; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Hearing Loss, Unilateral, Deafness, Unilateral
Interventions: The Cochlear™ Nucleus® Cochlear Implant (CI) System; Device
Lead sponsor: Cochlear; Industry
Eligibility: 5 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 6
States / cities: Palo Alto, California • Englewood, Colorado • Iowa City, Iowa + 3 more

Conditions: Rotator Cuff Tear
Interventions: Rotator cuff repair, Ibuprofen, Hydrocodone/Acetaminophen, Omeprazole, Hydrocodone/Acetaminophen; Procedure · Drug
Lead sponsor: University of Chicago; Other
Eligibility: 45 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myopia
Interventions: Topography-guided LASIK; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 59 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Heavy Menstrual Bleeding
Interventions: Juveena Hydrogel System; Device
Lead sponsor: Rejoni Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Little Rock, Arkansas • West Orange, New Jersey • Cincinnati, Ohio

Conditions: Distal Radius Fractures
Interventions: Generic Volar Locking Plate, Conventional Volar Locking Plate; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Small Cell Cancer Of The Lung, Small Cell Lung Cancer ( SCLC ), Lung Cancer, Small-Cell Lung Cancer (SCLC)
Interventions: Biospecimen collection; Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligodendroglioma, Astrocytoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Year to 99 Years
Enrollment: 674 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2015
U.S. locations: 3
States / cities: Bethesda, Maryland • New York, New York • Philadelphia, Pennsylvania

Conditions: Rotator Cuff Tear
Interventions: Early Motion Protocol, Immobilization; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: NanoString Technologies, Inc.; Industry
Eligibility: Female only
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Fort Myers, Florida • Scarborough, Maine • Bethesda, Maryland + 1 more

Conditions: Oropharyngeal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Head and Neck Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma
Interventions: Not listed
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2033
U.S. locations: 3
States / cities: Rochester, Minnesota • Chapel Hill, North Carolina • North Charleston, South Carolina

Conditions: Bone Regeneration
Interventions: GUIDOR® membrane with FDBA, GUIDOR® membrane, Bio-Gide® membrane with FDBA; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Los Angeles, California • Chapel Hill, North Carolina

Conditions: Pulmonary Arterial Hypertension
Interventions: Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 17
States / cities: Phoenix, Arizona • Tucson, Arizona • Sacramento, California + 14 more

Conditions: Diabetes, Hyperglycemia
Interventions: Insulin Glargine, Insulin, Insulin glulisine; Drug
Lead sponsor: Guillermo Umpierrez; Other
Eligibility: 60 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Décolleté Wrinkles
Interventions: Octave-Ultherapy treatment; Device
Lead sponsor: Merz North America, Inc.; Industry
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 10
States / cities: Beverly Hills, California • San Mateo, California • Norwalk, Connecticut + 6 more

Conditions: Hernia, Hernia, Ventral, Pathological Conditions, Anatomical, Hernia, Abdominal
Interventions: Integra® Gentrix® Surgical Matrix; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fort Myers, Florida

Search by objective public record fields.

Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Alveolar Bone Changes in Diabetes (ABCD) Study

Prospective Registry of Histotripsy for Soft Tissue Tumors

Lidocaine Patch for Epidural Placement Pain in Laboring Women

Pilot Study of High Risk Lung Cancer Screening

Safety for Frequent Use Conditions of Hair Removal Device

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

The Effect of NSAIDs After a Rotator Cuff Repair Surgery.

Topography-guided LASIK Surgery

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?

Prospective Multiomic Analysis in Small-Cell Lung Cancer

Genetic Analysis of Brain Tumors

Post-op Rehabilitation's Influence on Tendon Healing & Clinical Outcomes Following Arthroscopic Rotator Cuff Repair

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Diabetes in the Elderly: Prospective Study

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

T-GENVIH-003 LTFU (Long Term Follow Up) Study